CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY
Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting
Michael J. Zellweger, MD*,*,
Markus Weinbacher, MD*,
Andreas W. Zutter, MD*,
Raban V. Jeger, MD*,
Jan Mueller-Brand, MD ,
Christoph Kaiser, MD*,
Peter T. Buser, MD, FACC* and
Matthias E. Pfisterer, MD, FACC*
* Department of Cardiology, Basel, Switzerland
Nuclear Medicine, University Hospital, Basel, Switzerland.
Manuscript received October 11, 2002;
revised manuscript received February 3, 2003,
accepted March 7, 2003.
* Reprint requests and correspondence: Dr. Michael J. Zellweger, Department of Cardiology, University Hospital, Petersgraben 4, CH-4031, Basel, Switzerland.
mzellweger{at}uhbs.ch
This study was presented in part at the Fifth International Conference of Nuclear Cardiology, Vienna, Austria, May 2–5, 2001.
OBJECTIVES: We sought to evaluate the incidence of silent ischemia versus symptomatic ischemia six months after percutaneous coronary intervention (PCI) and its impact on prognosis and to test the utility of myocardial perfusion single-photon emission computed tomography (SPECT), or MPS, for risk stratification in these patients.
BACKGROUND: Silent ischemia is frequent after PCI. However, little is known about silent ischemia and long-term outcome after PCI and stenting.
METHODS: In 356 consecutive patients with successful PCI and stenting and follow-up MPS after six months, long-term follow-up (4.1 ± 0.3 years) was performed. The MPS images were interpreted by defining summed stress, rest, and difference scores (summed difference score [SDS] = extent of ischemia) and related to symptoms and outcome. Critical events included cardiac death, myocardial infarction, and target vessel revascularization.
RESULTS: Eighty-one patients (23%) had evidence of target vessel ischemia, which was silent in 62%. The only independent predictor of silent ischemia was SDS (odds ratio 0.64, p = 0.001). During follow-up, 67 critical events occurred. For patients with an SDS of 0, 1–4, and >4, the critical event rates were 17%, 29%, and 69%, respectively. Similarly, patients without ischemia, silent ischemia, and symptomatic ischemia had 17%, 32%, and 52% of critical events, respectively. Diabetes (relative risk 1.98, p = 0.03) and SDS (relative risk 1.2, p < 0.001) were independent predictors of critical events. The MPS image added incremental information for the prediction of critical events.
CONCLUSIONS: Six months after PCI and stenting, 23% of patients had target vessel ischemia, which was silent in 62%. Silent ischemia predicted a worse outcome than did no ischemia and tended to have a better outcome than symptomatic ischemia. This was closely related to the extent of ischemia. The SDS added incremental value to pre-scan findings with respect to diagnosis and prognosis, indicating the utility of MPS for risk stratification after PCI and stenting.
|
Abbreviations and Acronyms
| | CABG | | coronary artery bypass grafting | | CAD | | coronary artery disease | | ECG | | electrocardiogram/electrocardiographic | | MPS | | myocardial perfusion SPECT | | PCI | | percutaneous coronary intervention | | SDS | | summed difference score | | SPECT | | single-photon emission computed tomography | | SRS | | summed rest score | | SSS | | summed stress score | | Tc-99m | | technetium-99m |
|
This article has been cited by other articles:
|
|
|
|
 
G. A. Lin, R. A. Dudley, F. L. Lucas, D. J. Malenka, E. Vittinghoff, and R. F. Redberg
Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention
JAMA,
October 15, 2008;
300(15):
1765 - 1773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F Pugliese, A C Weustink, C Van Mieghem, F Alberghina, M Otsuka, W B Meijboom, N van Pelt, N R Mollet, F Cademartiri, G P Krestin, et al.
Dual source coronary computed tomography angiography for detecting in-stent restenosis
Heart,
July 1, 2008;
94(7):
848 - 854.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Zellweger, C. Kaiser, H. P. Brunner-La Rocca, P. T. Buser, S. Osswald, P. Weiss, J. Mueller-Brand, M. E. Pfisterer, and for the BASKET Investigators
Value and Limitations of Target-Vessel Ischemia in Predicting Late Clinical Events After Drug-Eluting Stent Implantation
J. Nucl. Med.,
April 1, 2008;
49(4):
550 - 556.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Erne, A. W. Schoenenberger, M. Zuber, D. Burckhardt, W. Kiowski, P. Dubach, T. Resink, and M. Pfisterer
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study
Eur. Heart J.,
September 1, 2007;
28(17):
2110 - 2117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Erne, A. W. Schoenenberger, D. Burckhardt, M. Zuber, W. Kiowski, P. T. Buser, P. Dubach, T. J. Resink, and M. Pfisterer
Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial
JAMA,
May 9, 2007;
297(18):
1985 - 1991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Rixe, S. Achenbach, D. Ropers, U. Baum, A. Kuettner, U. Ropers, W. Bautz, W. G. Daniel, and K. Anders
Assessment of coronary artery stent restenosis by 64-slice multi-detector computed tomography
Eur. Heart J.,
November 1, 2006;
27(21):
2567 - 2572.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Steg and D. Tchetche
Pharmacologic management of stable angina: role of ivabradine
Eur. Heart J. Suppl.,
September 1, 2006;
8(suppl_D):
D16 - D23.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Gilard, J C Cornily, P Y Pennec, G Le Gal, M Nonent, J Mansourati, J J Blanc, and J Boschat
Assessment of coronary artery stents by 16 slice computed tomography
Heart,
January 1, 2006;
92(1):
58 - 61.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Gabriel Steg and D. Himbert
Unmet medical needs and therapeutic opportunities in stable angina
Eur. Heart J. Suppl.,
September 1, 2005;
7(suppl_H):
H7 - H15.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sajadieh, O. W. Nielsen, V. Rasmussen, H. O. Hein, and J. F. Hansen
Prevalence and prognostic significance of daily-life silent myocardial ischaemia in middle-aged and elderly subjects with no apparent heart disease
Eur. Heart J.,
July 2, 2005;
26(14):
1402 - 1409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J Zellweger, R. Hachamovitch, X. Kang, S. W Hayes, J. D Friedman, G. Germano, M. E Pfisterer, and D. S Berman
Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients
Eur. Heart J.,
April 1, 2004;
25(7):
543 - 550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. N. Giedd and S. R. Bergmann
Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention
J. Am. Coll. Cardiol.,
February 4, 2004;
43(3):
328 - 336.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
